Works matching IS 20457634 AND DT 2022 AND VI 11 AND IP 4

Results: 30

Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1068, doi. 10.1002/cam4.4218

By:

Al Hamed, Rama;
Labopin, Myriam;
Daguindau, Etienne;
Niittyvuopio, Riitta;
Huynh, Anne;
Socié, Gerard;
Srour, Micha;
Bourhis, Jean Henri;
Kröger, Nicolaus;
Tholouli, Eleni;
Choi, Goda;
Poiré, Xavier;
Martin, Hans;
Rubio, Marie-Thérèse;
Jindra, Pavel;
Blaise, Didier;
Beelen, Dietrich;
Labussière-Wallet, Hélène;
Nagler, Arnon;
Bazarbachi, Ali

Publication type:

Article

Pre-diagnostic levels of sVEGFR2, sTNFR2, sIL-2Rα and sIL-6R are associated with glioma risk: A nested case-control study of repeated samples.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1016, doi. 10.1002/cam4.4505

By:

Yi-Ying Wu, Wendy;
Späth, Florentin;
Wibom, Carl;
Björkblom, Benny;
Dahlin, Anna M.;
Melin, Beatrice

Publication type:

Article

Multimodal MR imaging signatures to identify brain diffuse midline gliomas with H3 K27M mutation.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1048, doi. 10.1002/cam4.4500

By:

Xiaorui Su;
Yanhui Liu;
Haoyu Wang;
Ni Chen;
Huaiqiang Sun;
Xibiao Yang;
Weina Wang;
Simin Zhang;
Xinyue Wan;
Qiaoyue Tan;
Qiang Yue;
Qiyong Gong

Publication type:

Article

A clinical trial to compare a 3D-printed bolus with a conventional bolus with the aim of reducing cardiopulmonary exposure in postmastectomy patients with volumetric modulated arc therapy.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1037, doi. 10.1002/cam4.4496

By:

Yun Zhang;
Yuling Huang;
Shenggou Ding;
Jinghui Liang;
Jie Kuang;
Qingfeng Mao;
Weiliang Ying;
Yuxian Shu;
Jingao Li;
Chunling Jiang

Publication type:

Article

A real-world study of dacomitinib in later-line settings for advanced non-small cell lung cancer patients harboring EGFR mutations.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1026, doi. 10.1002/cam4.4495

By:

Hong-Shuai Li;
Jin-Yao Zhang;
Xiang Yan;
Hai-Yan Xu;
Xue-Zhi Hao;
Pu-Yuan Xing;
Yan Wang

Publication type:

Article

CORRIGENDUM.

Published in:: Cancer Medicine, 2022, v. 11, n. 4, p. 1244, doi. 10.1002/cam4.4489
Publication type:: Article

A B-Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1232, doi. 10.1002/cam4.4491

By:

Kevin Yao;
Emily Zhou;
Chao Cheng

Publication type:

Article

Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1217, doi. 10.1002/cam4.4514

By:

Seung In Seo;
Chan Hyuk Park;
Tae Jun Kim;
Chang Seok Bang;
Jae Young Kim;
Kyung Joo Lee;
Jinseob Kim;
Hyon Hee Kim;
Seng Chan You;
Woon Geon Shin

Publication type:

Article

Midlife brain metastases in the United States: Is male at risk?

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1202, doi. 10.1002/cam4.4499

By:

Wenqiang Che;
Yujiao Wang;
Xiangyu Wang;
Jun Lyu

Publication type:

Article

Disparities in telemedicine during COVID-19.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1192, doi. 10.1002/cam4.4518

By:

Qian, Alexander S.;
Schiaffino, Melody K.;
Nalawade, Vinit;
Aziz, Lara;
Pacheco, Fernanda V.;
Nguyen, Bao;
Vu, Peter;
Patel, Sandip P.;
Martinez, Maria Elena;
Murphy, James D.

Publication type:

Article

Missed opportunities for concomitant HPV vaccination among childhood cancer survivors.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1181, doi. 10.1002/cam4.4492

By:

Ramsay, Joemy M.;
Kaddas, Heydon K.;
Ou, Judy Y.;
Kepka, Deanna;
Kirchhoff, Anne C.

Publication type:

Article

Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire--a DCCSS LATER study.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1172, doi. 10.1002/cam4.4490

By:

Penson, Adriaan;
Walraven, Iris;
Bronkhorst, Ewald;
Grootenhuis, Martha A.;
Tissing, Wim J. E.;
van der Pal, Helena J. H.;
de Vries, Andrica C. H.;
van den Heuvel-Eibrink, Marry M.;
Neggers, Sebastian;
Versluys, Birgitta A. B.;
Louwerens, Marloes;
Pluijm, Saskia M. F.;
Blijlevens, Nicole;
van der Heiden-van der Loo, Margriet;
Kremer, Leontien C. M.;
van Dulmen-den Broeder, Eline;
Knoop, Hans;
Loonen, Jacqueline

Publication type:

Article

Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1160, doi. 10.1002/cam4.4484

By:

Offman, Judith;
Pesola, Francesca;
Fitzgerald, Rebecca C.;
Hamilton, Willie;
Sasieni, Peter

Publication type:

Article

Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol.

Published in:: Cancer Medicine, 2022, v. 11, n. 4, p. 1145, doi. 10.1002/cam4.4434
Publication type:: Article

The association of obesity with thyroid carcinoma risk.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1136, doi. 10.1002/cam4.4498

By:

Xiao-Ni Ma;
Cheng-Xu Ma;
Li-Jie Hou;
Song-Bo Fu

Publication type:

Article

Challenges posed by COVID-19 in cancer patients: A narrative review.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1119, doi. 10.1002/cam4.4519

By:

Afshar, Zeinab Mohseni;
Hosseinzadeh, Rezvan;
Barary, Mohammad;
Ebrahimpour, Soheil;
Alijanpour, Amirmasoud;
Sayad, Babak;
Hosseinzadeh, Dariush;
Miri, Seyed Rouhollah;
Sio, Terence T.;
Sullman, Mark J. M.;
Carson-Chahhoud, Kristin;
Babazadeh, Arefeh

Publication type:

Article

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity-modulated radiotherapy era.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1109, doi. 10.1002/cam4.4520

By:

Shan-Shan Yang;
Ya-Jun Pang;
Zhi-Qiang Wang;
Bao-Yu Zhang;
Zhi-Qiao Liu;
En-Ni Chen;
Pu-Yun OuYang;
Fang-Yun Xie

Publication type:

Article

Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1099, doi. 10.1002/cam4.4517

By:

Prakash, Ipshita;
Neely, N. Ben;
Thomas, Samantha M.;
Sammons, Sarah;
Blitzblau, Rachel C.;
DiLalla, Gayle A.;
Hyslop, Terry;
Menendez, Carolyn S.;
Plichta, Jennifer K.;
Rosenberger, Laura H.;
Fayanju, Oluwadamilola M.;
Hwang, E. Shelley;
Greenup, Rachel A.

Publication type:

Article

Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1088, doi. 10.1002/cam4.4512

By:

Shun Tezuka;
Makoto Ueno;
Ritsuko Oishi;
Shuhei Nagashima;
Yusuke Sano;
Kuniyuki Kawano;
Satoshi Tanaka;
Taito Fukushima;
Hiroyuki Asama;
Naoki Konno;
Satoshi Kobayashi;
Manabu Morimoto;
Shin Maeda

Publication type:

Article

Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1081, doi. 10.1002/cam4.4507

By:

Ying Cheng;
Qiming Wang;
Kai Li;
Jianhua Shi;
Lin Wu;
Baohui Han;
Gongyan Chen;
Jianxing He;
Jie Wang;
Haifeng Qin;
Xiaoling Li

Publication type:

Article

Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1005, doi. 10.1002/cam4.4523

By:

Stikbakke, Einar;
Schirmer, Henrik;
Knutsen, Tore;
Støyten, Martin;
Wilsgaard, Tom;
Giovannucci, Edward L.;
McTiernan, Anne;
Eggen, Anne E.;
Haugnes, Hege S.;
Richardsen, Elin;
Thune, Inger

Publication type:

Article

Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 1059, doi. 10.1002/cam4.4501

By:

Xi Luo;
Xiaodong Huang;
Shaoyan Liu;
Xiaolei Wang;
Jingwei Luo;
Jianping Xiao;
Kai Wang;
Yuan Qu;
Xuesong Chen;
Ye Zhang;
Jingbo Wang;
Jianghu Zhang;
Guozhen Xu;
Li Gao;
Runye Wu;
Junlin Yi

Publication type:

Article

Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 993, doi. 10.1002/cam4.4486

By:

Chia-Ying Wu;
Yi-Jou Tai;
I-Lun Shih;
Ying-Cheng Chiang;
Yu-Li Chen;
Heng-Cheng Hsu;
Wen-Fang Cheng

Publication type:

Article

Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 983, doi. 10.1002/cam4.4485

By:

Hiroyuki Kuwano;
Takehiko Yokobori;
Munenori Ide;
Hiroshi Saeki;
Makoto Sohda;
Makoto Sakai;
Tomonori Yoshida;
Kengo Kuriyama;
Kyoichi Ogata;
Hiroomi Ogawa;
Takuhisa Okada;
Tatsuya Miyazaki;
Shunsuke Takahashi;
Ken Shirabe

Publication type:

Article

Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 956, doi. 10.1002/cam4.4506

By:

Weitzenböck, Hans Peter;
Gschwendtner, Anna;
Wiesner, Christoph;
Depke, Maren;
Schmidt, Frank;
Trautinger, Franz;
Hengstschläger, Markus;
Hundsberger, Harald;
Mikula, Mario

Publication type:

Article

Heterogeneity among tumors with acquired resistance to EGFR tyrosine kinase inhibitors harboring EGFR-T790M mutation in non-small cell lung cancer cells.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 944, doi. 10.1002/cam4.4504

By:

Yuki Katayama;
Tadaaki Yamada;
Shinsaku Tokuda;
Naoko Okura;
Naoya Nishioka;
Kenji Morimoto;
Keiko Tanimura;
Yoshie Morimoto;
Masahiro Iwasaku;
Mano Horinaka;
Toshiyuki Sakai;
Kenji Kita;
Seiji Yano;
Koichi Takayama

Publication type:

Article

The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 931, doi. 10.1002/cam4.4521

By:

Xiaoli Zhang;
Na Li;
Ying Zhu;
Wei Wen

Publication type:

Article

Hypoxia promotes the tolerogenic phenotype of plasmacytoid dendritic cells in head and neck squamous cell carcinoma.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 922, doi. 10.1002/cam4.4511

By:

Cui Fan;
Jichang Wu;
Yilin Shen;
Haixia Hu;
Quan Wang;
Yufeng Mao;
Bin Ye;
Mingliang Xiang

Publication type:

Article

Glycan signatures for the identification of cisplatin-resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG).

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 968, doi. 10.1002/cam4.4515

By:

Hires, Michal;
Jane, Eduard;
Kalavska, Katarina;
Chovanec, Michal;
Mego, Michal;
Kasak, Peter;
Bertok, Tomas;
Tkac, Jan

Publication type:

Article

Neurobiology of cancer: Definition, historical overview, and clinical implications.

Published in:

Cancer Medicine, 2022, v. 11, n. 4, p. 903, doi. 10.1002/cam4.4488

By:

Mravec, Boris

Publication type:

Article